Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
Authors
Keywords
-
Journal
Oncogenesis
Volume 3, Issue 5, Pages e104-e104
Publisher
Springer Nature
Online
2014-05-26
DOI
10.1038/oncsis.2014.17
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miRNA-205 affects infiltration and metastasis of breast cancer
- (2013) Zhouquan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells
- (2013) Xiao-feng Zhai et al. BMC Complementary and Alternative Medicine
- miR-146b-5p inhibits glioma migration and invasion by targeting MMP16
- (2013) Yanyan Li et al. CANCER LETTERS
- Alterations of epigenetics and microRNA in hepatocellular carcinoma
- (2013) Yoshimasa Saito et al. HEPATOLOGY RESEARCH
- Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication
- (2013) Ayami Sato et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4
- (2012) H.-Y. Chen et al. CANCER RESEARCH
- miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
- (2012) Dan-Xia Zhu et al. CARCINOGENESIS
- Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
- (2012) A. Avan et al. MOLECULAR CANCER THERAPEUTICS
- The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1
- (2012) N. Cai et al. RNA
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer
- (2011) S. Majid et al. CANCER RESEARCH
- The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network
- (2011) M Fareh et al. CELL DEATH AND DIFFERENTIATION
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- p53 downregulates Down syndrome-associated DYRK1A through miR-1246
- (2011) Yu Zhang et al. EMBO REPORTS
- 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
- (2011) Tetsuhiro Chiba et al. INTERNATIONAL JOURNAL OF CANCER
- miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells
- (2011) Ke Xu et al. MOLECULAR CARCINOGENESIS
- MicroRNAs in Hepatobiliary and Pancreatic Cancers
- (2011) Yoshimasa Saito et al. Frontiers in Genetics
- MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
- (2010) Zhang Chun-zhi et al. BMC CANCER
- hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion and side populations
- (2010) F Wang et al. BRITISH JOURNAL OF CANCER
- MiR-146b-5p Suppresses EGFR Expression and ReducesIn VitroMigration and Invasion of Glioma
- (2010) Mark Katakowski et al. CANCER INVESTIGATION
- MicroRNA miR-302 Inhibits the Tumorigenecity of Human Pluripotent Stem Cells by Coordinate Suppression of the CDK2 and CDK4/6 Cell Cycle Pathways
- (2010) S.-L. Lin et al. CANCER RESEARCH
- Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
- (2010) F. Orzan et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Regulation of somatic cell reprogramming through inducible mir-302 expression
- (2010) Shi-Lung Lin et al. NUCLEIC ACIDS RESEARCH
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Girding for migratory cues: roles of the Akt substrate Girdin in cancer progression and angiogenesis
- (2009) Liang Weng et al. CANCER SCIENCE
- p38α- and DYRK1A-dependent phosphorylation of caspase-9 at an inhibitory site in response to hyperosmotic stress
- (2009) Anne Seifert et al. CELLULAR SIGNALLING
- miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis
- (2009) Christoph A Gebeshuber et al. EMBO REPORTS
- The role of microRNAs in gastrointestinal cancers
- (2009) Yoshimasa Saito et al. JOURNAL OF GASTROENTEROLOGY
- MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells
- (2009) Jiaqiang Ren et al. Journal of Translational Medicine
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells
- (2009) Y Saito et al. ONCOGENE
- An Actin-Binding Protein Girdin Regulates the Motility of Breast Cancer Cells
- (2008) P. Jiang et al. CANCER RESEARCH
- The Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development
- (2008) Ariadna Laguna et al. DEVELOPMENTAL CELL
- miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
- (2008) Zhiyu Zhang et al. LABORATORY INVESTIGATION
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state
- (2008) S.-L. Lin et al. RNA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started